Physician

Angela M Iacobelli, M.D.

According to 2025 Medicare claims, Angela Iacobelli, M.D. (NPI: 1154356962) practices allergy/immunology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is ALLERGY AND ASTHMA SPECIALISTS OF MICHIGAN, PLLC (NPI: 1295225811; TIN: 825285770) and primary practice location at 48313-1961.

Iacobelli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 128 traditional Medicare patients, billed 3,466 HCPCS/CPT codes, and received $46,097 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,322 prescription claims across 232 beneficiaries totaling $653,424 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 51 claims. Open Payments data shows 110 records totaling $2,451. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	130	2,221	$34,589
2016	146	3,156	$45,193
2017	128	2,467	$37,654
2018	114	2,631	$30,757
2019	123	3,947	$53,746
2020	120	2,972	$39,144
2021	125	3,867	$46,663
2022	139	3,851	$47,992
2023	125	3,626	$44,521
2024	128	3,466	$46,097

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	179	990	$341,703
2016	210	1,098	$434,063
2017	194	1,141	$436,303
2018	169	964	$440,222
2019	171	1,108	$384,853
2020	180	1,136	$419,224
2021	188	1,164	$400,282
2022	213	1,175	$395,703
2023	235	1,314	$466,401
2024	232	1,322	$653,424

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	13	102	$13,238
2016	N/R	123	$9,448
2017	N/R	138	$18,807
2018	N/R	69	$17,889
2019	N/R	92	$19,566
2020	N/R	57	$17,424
2021	N/R	N/R	N/R
2022	N/R	11	$31,063
2023	N/R	11	$485
2024	N/R	51	$1,074

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	96	195	$91
94010	Test to measure expiratory airflow and volume	73	159	$20
95024	Test for allergy using allergenic extract injected into skin	29	365	$6
95004	Test for allergy using allergenic extract	32	1,822	$3
96160	Administration and interpretation of patient-focused health risk assessment	74	181	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	121	6,661	$134,561
Xolair	Omalizumab	29	924	$132,737
Dupixent Pen	Dupilumab	19	532	$70,015
Hyqvia	Igg/Hyaluronidase,recombinant	14	392	$66,704
Nucala	Mepolizumab	11	308	$37,493

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	15	$698
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	N	N/R	18	$307
E0570	Nebulizer, with compressor	Y	N/R	18	$69

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	110	$2,451	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Angela M. Iacobelli, M.D.?

Tedicare shows public-source Medicare data for Angela M. Iacobelli, M.D. (NPI 1154356962), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Angela M. Iacobelli, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Angela M. Iacobelli, M.D.?

Angela M. Iacobelli, M.D. is linked to ALLERGY AND ASTHMA SPECIALISTS OF MICHIGAN, PLLC (billing NPI 1295225811) in the available physician profile data.

Does Angela M. Iacobelli, M.D. have Open Payments data?

Angela M. Iacobelli, M.D. has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.